VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Chemed Executive Compensation (FY25)

CHE · Cincinnati, OH · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Kevin McNamara
Median of the other named officers
$3,208,764
5 officers, excluding the chief executive
Latest say-on-pay support
=
May 18, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The Chemed brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of November 3, 2026Latest filing (8-K): May 19, 2026
17 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Chemed brief$500Get the executive brief
Velarion Intel, one year, every company
327 figures on this page: 316 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Kevin McNamara: $12,769,564 → $12,904,720 (1.1% higher)
Say-on-pay support: 87.0% → 38.8% (48.2 points lower)
CEO pay ratio: 229:1 → 209:1 (8.7% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Chemed's chief executive and what were they paid?
Total compensation for Kevin McNamara, President and CEO, came to $12,904,720 in fiscal 2025. Compared with the $12,769,564 reported for fiscal 2024, McNamara's total was 1.1% higher.
What was Chemed's say-on-pay result?
Shareholders supported the say-on-pay proposal with 38.8% of votes cast for or against in favor at the meeting held May 18, 2026 for fiscal 2025.
Which companies are in Chemed's peer group?
The disclosed peer group names ABM Industries, Inc., Acadia Healthcare Co., Inc., Addus Homecare Corp., AMN Healthcare Services, Inc. and Brookdale Senior Living, Inc., among others.
What is Chemed's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 209:1, against median employee compensation of $61,813.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin McNamara
President and Chief Executive Officer
◇—◇◇◇◇◇◇
David Williams
Executive Vice President and Chief Financial Officer
◇—◇◇◇◇◇◇
Nicholas Westfall
President and Chief Executive Officer, VITAS Healthcare Corporation
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin McNamara
President and CEO
◇—◇◇◇◇◇◇
Nicholas Westfall
Former Executive Vice President
◇—◇◇◇—◇◇
David Williams
Executive Vice President and CFO
◇—◇—◇◇◇◇
Spencer Lee
Executive Vice President
◇—◇◇◇◇◇◇
Michael Witzeman
Executive Vice President, CFO and Controller
◇—◇◇◇—◇◇
Thomas Hutton
Vice President
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin McNamara
President and CEO
◇—◇◇◇◇◇◇
Nicholas Westfall
Former Executive Vice President
◇—◇◇◇—◇◇
Michael Witzeman
Executive Vice President, CFO and Controller
◇—◇◇◇—◇◇
Spencer Lee
Executive Vice President
◇—◇◇◇◇◇◇
Brian Judkins
Vice President, Secretary and Chief Legal Officer
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin McNamara
President and CEO
◇—◇◇◇◇◇◇
Nicholas Westfall
Former Executive Vice President
Departed during or after this year
◇—————◇◇
Michael Witzeman
Executive Vice President, CFO and Controller
◇—◇◇◇—◇◇
Spencer Lee
Executive Vice President
◇—◇◇◇◇◇◇
Joel Wherley
Vitas President and Chief Executive Officer
◇◇◇◇—◇—◇
Brian Judkins
Vice President, Secretary and Chief Legal Officer
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Brian JudkinsRSU◇——◇——◇
Brian JudkinsOPTION◇——◇—◇◇
Brian JudkinsRSU◇——◇——◇
Joel WherleyRSU◇——◇——◇
Joel WherleyRSU◇——◇——◇
Joel WherleyOPTION◇——◇—◇◇
Kevin McNamaraRSU◇——◇——◇
Kevin McNamaraOPTION◇——◇—◇◇
Kevin McNamaraRSU◇——◇——◇
Michael WitzemanRSU◇——◇——◇
Michael WitzemanRSU◇——◇——◇
Michael WitzemanOPTION◇——◇—◇◇
Nicholas WestfallRSU◇——◇——◇
Nicholas WestfallRSU◇——◇——◇
Spencer LeeRSU◇——◇——◇
Spencer LeeRSU◇——◇——◇
Spencer LeeOPTION◇——◇—◇◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Michael WitzemanOption◇—◇10/21/2030
Option◇—◇10/22/2029
Option◇—◇10/25/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
Joel WherleyOption◇—◇10/21/2030
Option◇—◇10/22/2029
Option◇—◇10/25/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
Brian JudkinsOption◇—◇10/21/2030
Option◇—◇10/22/2029
Option◇—◇10/25/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
Spencer LeeOption◇—◇10/21/2030
Option◇—◇10/22/2029
Option◇—◇10/25/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Brian Judkins
Vice President, Secretary and Chief Legal Officer · Severance agreement
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation on change in control◇
Benefits continuation◇
Joel Wherley
Vitas President and Chief Executive Officer · Severance agreement
Equity acceleration on change in control◇
Kevin McNamara
President and CEO · Change-in-control agreement
Equity acceleration on change in control◇
Michael Witzeman
Executive Vice President, CFO and Controller · Severance agreement
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation on change in control◇
Benefits continuation◇
Clawback◇
Nicholas Westfall
Former Executive Vice President · Severance agreement
Equity acceleration on change in control◇
Spencer Lee
Executive Vice President · Severance agreement
Equity acceleration on change in control◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
George J. Walsh III
Board chair
◇◇———◇◇
Patrick P. Grace
◇◇————◇
Christopher J. Heaney
◇◇————◇
John M. Mount Jr
◇◇————◇
Ron DeLyons
◇◇————◇
Andrea R. Lindell
◇◇————◇
Eileen P. McCarthy
◇◇————◇
Thomas P. Rice
◇◇————◇
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Board meeting fee◇
Committee meeting fee◇
Equity is delivered as Stock.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • ABM Industries, Inc. ABM
  • Acadia Healthcare Co., Inc. HR
  • Addus Homecare Corp. ADUS
  • AMN Healthcare Services, Inc. AMN
  • Brookdale Senior Living, Inc. BKD
  • Clean Harbors, Inc. CLH
  • Comfort Systems USA, Inc. FIX
  • Encompass Health Corp. EHC
  • Healthcare Services Group, Inc. HCSG
  • National Healthcare Corp. NHC
  • Option Care Health, Inc. OPCH
  • Pediatrix Medical Group MD
  • RadNet, Inc. RDNT
  • Rollins, Inc. ROL
  • Select Medical Holdings Corp. SEM
  • Surgery Partners, Inc. SGRY
  • Team, Inc. TISI
  • Tetra Tech, Inc. TTEK
  • The Ensign Group, Inc. ENSG

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 18, 2026=◇◇◇
2024May 19, 2025=◇◇◇
2023May 20, 2024=◇◇◇
2022May 15, 2023=◇◇◇
2021May 16, 2022=◇◇◇
2020May 17, 2021=◇◇◇
2019May 18, 2020=◇◇◇
2018May 20, 2019=◇◇◇
2017May 21, 2018=◇◇◇
2016May 15, 2017=◇◇◇
2015May 16, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Kevin McNamara (President and CEO), FY2025 total compensation $12,904,720 (base salary $1,858,792) [exec_comp, SEC accession 0001562762-26-000052, filed 2026-04-09]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Chemed files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Chemed disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Chemed sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Say-on-pay responsiveness
Chemed recorded a low support level. The responsiveness analysis covers what the company said it would do, what it did, and how that compares with the companies that recovered their vote.
Responsiveness analysis
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Chemed's disclosed peer group is defensible, who names Chemed back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
327 figures on this page: 316 cited to the filing that reported them, 11 calculated from figures it prints.
316 cited to the filing
11 calculated from the filing

Documents cited

  1. 0000019584-26-000014
  2. 0001562762-26-000052
    Grants of Plan-Based Awards · Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table · Outstanding Equity Awards at Fiscal Year End
  3. 0000019584-26-000005
    Grants of Plan-Based Awards
  4. 0001562762-26-000020
    Exhibit
  5. 0001562762-25-000136
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001562762-24-000146
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001562762-24-000082
    Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table
  8. 0001562762-23-000250
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001562762-23-000159
    Summary Compensation Table
  10. 0001562762-22-000254
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001562762-21-000230
  12. 0001562762-20-000204
  13. 0001157523-19-001278
  14. 0001157523-18-001180
    Item 5.07 Submission of Matters to a Vote of Security Holders
  15. 0001157523-17-001596
    Item 5.07 Submission of Matters to a Vote of Security Holders
  16. 0001157523-16-005660
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Chemed executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/CHE (accessed 2026).
Short form: data: Velarion

The Chemed brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
17 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Chemed and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Chemed discloses

The companies named in CHE's own disclosed peer group.

ABM Industries, Inc.Acadia Healthcare Co., Inc.Addus Homecare Corp.AMN Healthcare Services, Inc.Brookdale Senior Living, Inc.Clean Harbors, Inc.Comfort Systems USA, Inc.Encompass Health Corp.Healthcare Services Group, Inc.National Healthcare Corp.Option Care Health, Inc.Pediatrix Medical GroupRadNet, Inc.Rollins, Inc.Select Medical Holdings Corp.Surgery Partners, Inc.Team, Inc.Tetra Tech, Inc.The Ensign Group, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy